Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0000905148-25-000686)

Filing Details

Accession Number:: 0000905148-25-000686
Form Type:: 13G Filing
Publication Date:: 2025-02-13 19:00:00

Filed By:: NOMURA HOLDINGS INC
Company:: Poseida Therapeutics Inc. (NASDAQ:PSTX)
Filing Date:: 2025-02-14
SEC Url:: 13G Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Beneficially Owned Number of Shares	Beneficially Owned Number of Aggregate Shares	Percent of Class
NOMURA HOLDINGS INC	0	5,115,015	5.2%
NOMURA GLOBAL FINANCIAL PRODUCTS INC	0	5,115,015	5.2%

Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Poseida Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

73730P108

(CUSIP Number)

12/31/2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

73730P108

Names of Reporting Persons

NOMURA HOLDINGS INC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 5,115,015.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 5,115,015.00

Aggregate Amount Beneficially Owned by Each Reporting Person

5,115,015.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.2 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: (1) Shared voting and dispositive power represents 5,115,015 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"). NGFP is a wholly owned subsidiary of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP. (2) The percent of class is calculated based on 97,774,206 shares of Common Stock outstanding as of December 2, 2024, as reported in the Issuer's Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on December 9, 2024.

SCHEDULE 13G

CUSIP No.

73730P108

Names of Reporting Persons

NOMURA GLOBAL FINANCIAL PRODUCTS INC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 5,115,015.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 5,115,015.00

Aggregate Amount Beneficially Owned by Each Reporting Person

5,115,015.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.2 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: (3) The percent of class is calculated based on 97,774,206 shares of Common Stock outstanding as of December 2, 2024, as reported in the Issuer's Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on December 9, 2024.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Poseida Therapeutics, Inc.

(b)

Address of issuer's principal executive offices:

9390 Towne Centre Drive, Suite 200, San Diego, California, 92121

Item 2.

(a)

Name of person filing:

Nomura Holdings, Inc. Nomura Global Financial Products, Inc.

(b)

Address or principal business office or, if none, residence:

Nomura Holdings, Inc.: 13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan Nomura Global Financial Products, Inc.: Worldwide Plaza 309 West 49th Street New York, NY 10019

(c)

Citizenship:

Nomura Holdings, Inc.: Japan Nomura Global Financial Products, Inc.: Delaware

(d)

Title of class of securities:

Common Stock, par value $0.0001 per share

(e)

CUSIP No.:

73730P108

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

Items 5-11 of the cover pages are incorporated by reference.

(b)

Percent of class:

Nomura Holdings, Inc.: 5.2 % Nomura Global Financial Products, Inc.: 5.2

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

Items 5-11 of the cover pages are incorporated by reference.

(ii) Shared power to vote or to direct the vote:

Items 5-11 of the cover pages are incorporated by reference.

(iii) Sole power to dispose or to direct the disposition of:

Items 5-11 of the cover pages are incorporated by reference.

(iv) Shared power to dispose or to direct the disposition of:

Items 5-11 of the cover pages are incorporated by reference.

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

See Exhibit B

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NOMURA HOLDINGS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Managing Director
Date:	02/14/2025

NOMURA GLOBAL FINANCIAL PRODUCTS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Authorized Officer
Date:	02/14/2025

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Subsidiaries